Marshall Wace’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Sell
68,343
-115,411
-63% -$30.7M 0.02% 751
2025
Q4
$45.3M Buy
183,754
+54,794
+42% +$11.5M 0.04% 364
2025
Q3
$22.8M Buy
128,960
+16,578
+15% +$2.48M 0.03% 596
2025
Q2
$15.4M Buy
112,382
+95,158
+552% +$14M 0.02% 678
2025
Q1
$3.11M Buy
17,224
+6,893
+67% +$1.16M ﹤0.01% 1271
2024
Q4
$1.62M Buy
+10,331
New +$1.83M ﹤0.01% 1528
2024
Q2
Sell
-5,600
Closed -$996K 2781
2024
Q1
$996K Sell
5,600
-65,301
-92% -$9.07M ﹤0.01% 1651
2023
Q4
$8.8M Buy
70,901
+61,373
+644% +$6.81M 0.02% 725
2023
Q3
$1.11M Buy
+9,528
New +$1.16M ﹤0.01% 1464
2023
Q2
Sell
-8,571
Closed -$686K 2763
2023
Q1
$686K Sell
8,571
-3,629
-30% -$285K ﹤0.01% 1971
2022
Q4
$966K Buy
+12,200
New +$906K ﹤0.01% 2107
2022
Q1
Sell
-108,511
Closed -$7.59M 3739
2021
Q4
$7.59M Buy
108,511
+82,856
+323% +$4.82M 0.02% 1068
2021
Q3
$1.34M Buy
+25,655
New +$1.52M 0.01% 1818
2021
Q2
Sell
-29,836
Closed -$2.3M 2891
2021
Q1
$2.3M Buy
29,836
+22,409
+302% +$1.63M 0.01% 1255
2020
Q4
$446K Buy
+7,427
New +$371K ﹤0.01% 1501

Other funds holding KRYS